Are you an #Olympics expert? 💯 Discover the answer tomorrow morning, answer will be in the comments! #GenScript #Sports #Biotech #ScienceTrivia #Quiz
This content isn’t available here
Access this content and more in the LinkedIn app
Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific. Today, over 200,000 customers from over 100+ countries and regions worldwide have used GenScript’s premier, convenient, and reliable products and services. GenScript has over 6,900 employees globally, with about 10% R&D personnel. In addition, GenScript has a number of leading commercial technologies developed in the fields of synthetic biology, immunotherapy, antibody design, chemical synthesis, and bioinformatics, including more than 300 patents and about 900 patent applications. As of December 31, 2023, GenScript's products and services have been cited by 87,745 scientific papers worldwide. GenScript is committed to striving toward its vision of being the most reliable biotech company in the world to make humans and nature healthier through biotechnology.
External link for GenScript
860 Centennial Ave
Piscataway, NJ 08854, US
Are you an #Olympics expert? 💯 Discover the answer tomorrow morning, answer will be in the comments! #GenScript #Sports #Biotech #ScienceTrivia #Quiz
This content isn’t available here
Access this content and more in the LinkedIn app
📊 Case Study Insight: Combinatorial mutant library in Genscript combined with phage display screened antibody with over 100-fold affinity maturated by SPR validation. Learn more how DNA mutant Library contribute your antibody discovery and engineering! 🚀 Facilitate HTP screen Antibody discovery with GenScript’s DNA Mutant Library! 🚀 Why struggle with massive diversity library for leads discovery? Embrace the future of antibody engineering with Combinatorial Mutant Library. Download for free now:https://lnkd.in/eT5-MH6p #DNAMutantLibrary #AntibodyDiscovery #applicationnote #ReliabilityisinourGenes #ReliableService
Celebrating happy moments with a few of our recent #Stanley winners!🎇🎁 Want your own Stanley tumbler? 🔥Last call to complete the mRNA survey and join our growing list of happy winners! 🥳 👉🔗Start the Survey Now: https://bit.ly/4cpNv9R A massive shoutout to Elanur Yılmaz, Oana Teodora Truica (Marisca) and Haoyuan Li for sharing their fantastic photos with their new Stanley tumblers. Thank you all for sharing your joy with us! 😊 #mRNA #Research #Giveaway #GenScript #Innovation #CustomerAppreciation #IVTRNA #RNA #Stanley
🔬 𝟭𝟬𝟬% 𝗣𝗹𝗮𝘀𝗺𝗶𝗱 𝗬𝗶𝗲𝗹𝗱 𝗚𝘂𝗮𝗿𝗮𝗻𝘁𝗲𝗲 – 𝗣𝗹𝗮𝘀𝗺𝗶𝗱 𝗗𝗡𝗔 𝗣𝗿𝗲𝗽𝗮𝗿𝗮𝘁𝗶𝗼𝗻 𝗦𝗲𝗿𝘃𝗶𝗰𝗲! 𝗬𝗼𝘂𝗿 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵, 𝗪𝗲 𝗚𝘂𝗮𝗿𝗮𝗻𝘁𝗲𝗲. With GenScript’s plasmid DNA preparation services, we guarantee plasmid yield for all projects, no matter the difficulty. Whether your plasmids are low-copy, toxic, or unstable, let us handle it while you focus on discovery. Learn More: https://lnkd.in/e8cAkg7A Easy Ordering with GenSmart™ 2.0 Online Ordering Platform: https://lnkd.in/eiXm77MK #PlasmidDNAPreparation #Guaranteeyield #Reliabilityisinourgenes
Celebrating RNA Day with a twist! 🧬 On this special day, we honor the incredible world of RNA and its groundbreaking impact on biotech. And, because it's also National Girlfriend Day, we’re sharing the love with all the amazing women who support us in our journey. Here's to the power of science and the strength of our bonds! 💘 #RNADay #NationalGirlfriendDay #BiotechLove
🌟 Registered for our LIVE GCE Summit but couldn't attend? No worries! You can still catch all the inspiring talks and insightful sessions on-demand, anytime, anywhere. Access groundbreaking ideas and innovations here: https://bit.ly/3KZvC5O 🎥 Watch on demand, all year round! #GCESummit #WatchOnDemand #CellEngineering #Genetics #Innovation #Leadership
What is Fibrolamellar carcinoma (FLC)? A rare form of liver carcinoma that affects the young. DNAJ-PKAc, a fusion protein frequently found within the tumor drives this rare form of hepatocellular carcinoma. Recently a team at St. Jude Children’s Research Hospital, led by Dr. Paul G Thomas, has explored the potential of leveraging DNAJ-PKA fusion neoantigens for immunotherapy in FLC patients. Read here: https://lnkd.in/emZ7WUxE #Neoantigen #Tcells #syntheticpeptides #Cancerresearch #Immunology #Research #Health #Science